Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.43 | 0.43 | 0.00 |
Shares | 99.57 | 99.57 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 32.96 | 28.08 |
Price to Book | 7.35 | 6.67 |
Price to Sales | 5.15 | 4.19 |
Price to Cash Flow | 19.52 | 18.58 |
Dividend Yield | 0.46 | 0.71 |
5 Years Earnings Growth | 18.06 | 14.90 |
Name | Net % | Category Average |
---|---|---|
Technology | 44.39 | 38.73 |
Communication Services | 12.36 | 11.08 |
Healthcare | 10.67 | 12.82 |
Consumer Cyclical | 10.62 | 14.15 |
Financial Services | 9.62 | 9.28 |
Industrials | 7.86 | 7.23 |
Consumer Defensive | 1.57 | 3.80 |
Energy | 1.48 | 1.83 |
Basic Materials | 0.91 | 1.90 |
Real Estate | 0.52 | 1.68 |
Number of long holdings: 92
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft Corp | - | 9.64 | - | - | |
NVIDIA Corp | - | 8.98 | - | - | |
Amazon.com Inc | - | 6.92 | - | - | |
Meta Platforms Inc Class A | - | 4.86 | - | - | |
Alphabet Inc Class C | - | 4.00 | - | - | |
Apple Inc | - | 3.95 | - | - | |
Mastercard Inc Class A | - | 3.93 | - | - | |
Advanced Micro Devices Inc | - | 2.16 | - | - | |
KKR & Co Inc Ordinary Shares | - | 1.95 | - | - | |
Eli Lilly and Co | - | 1.79 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco American Franchise A | 14.41B | 9.04 | 3.10 | 12.82 | ||
Invesco Equity and Income A | 10.21B | 3.43 | 3.48 | 6.94 | ||
Invesco Comstock A | 6.68B | 5.87 | 9.87 | 9.25 | ||
Invesco Diversified Dividend A | 3.95B | 4.17 | 5.69 | 7.52 | ||
Invesco Charter A | 3.18B | 6.54 | 5.20 | 7.85 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review